Quoin Pharmaceuticals Ltd. operates as a specialty pharmaceutical company. The Company focuses on developing and commercializing therapeutic products that treat rare and orphan diseases. Quoin Pharmaceuticals serves customers worldwide.

424B3 | Prospectus

Current Report (Form 8-K | Period ending 2024-11-07)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Quoin Pharmaceuticals (QNRX US)

424B3 | Prospectus

Current Report (Form 8-K | Period ending 2024-11-07)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-10-29)

Annual Report to Security Holders (Form ARS | Period ending 2023-12-31)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)